Arcadia Biosciences Statistics
Total Valuation
RKDA has a market cap or net worth of $1.88 million. The enterprise value is -$1.84 million.
Important Dates
The last earnings date was Thursday, May 14, 2026, after market close.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
RKDA has 2.06 million shares outstanding. The number of shares has increased by 13.40% in one year.
| Current Share Class | 2.06M |
| Shares Outstanding | 2.06M |
| Shares Change (YoY) | +13.40% |
| Shares Change (QoQ) | +51.82% |
| Owned by Insiders (%) | 0.55% |
| Owned by Institutions (%) | 3.67% |
| Float | 1.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.39 |
| Forward PS | 0.30 |
| PB Ratio | 0.65 |
| P/TBV Ratio | 0.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.79
| Current Ratio | 3.79 |
| Quick Ratio | 3.04 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -158.15% and return on invested capital (ROIC) is -50.90%.
| Return on Equity (ROE) | -158.15% |
| Return on Assets (ROA) | -32.83% |
| Return on Invested Capital (ROIC) | -50.90% |
| Return on Capital Employed (ROCE) | -121.50% |
| Weighted Average Cost of Capital (WACC) | 7.13% |
| Revenue Per Employee | $594,750 |
| Profits Per Employee | -$1.17M |
| Employee Count | 8 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 2.94 |
Taxes
In the past 12 months, RKDA has paid $8,000 in taxes.
| Income Tax | 8,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -78.65% in the last 52 weeks. The beta is 0.52, so RKDA's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | -78.65% |
| 50-Day Moving Average | 1.25 |
| 200-Day Moving Average | 2.69 |
| Relative Strength Index (RSI) | 29.56 |
| Average Volume (20 Days) | 3,095,859 |
Short Selling Information
The latest short interest is 6,339, so 0.31% of the outstanding shares have been sold short.
| Short Interest | 6,339 |
| Short Previous Month | 1,595 |
| Short % of Shares Out | 0.31% |
| Short % of Float | 0.36% |
| Short Ratio (days to cover) | 0.26 |
Income Statement
In the last 12 months, RKDA had revenue of $4.76 million and -$9.32 million in losses. Loss per share was -$6.03.
| Revenue | 4.76M |
| Gross Profit | 1.63M |
| Operating Income | -4.81M |
| Pretax Income | -9.32M |
| Net Income | -9.32M |
| EBITDA | -4.78M |
| EBIT | -4.81M |
| Loss Per Share | -$6.03 |
Full Income StatementBalance Sheet
The company has $3.72 million in cash and n/a in debt, with a net cash position of $3.72 million or $1.81 per share.
| Cash & Cash Equivalents | 3.72M |
| Total Debt | n/a |
| Net Cash | 3.72M |
| Net Cash Per Share | $1.81 |
| Equity (Book Value) | 2.89M |
| Book Value Per Share | 1.40 |
| Working Capital | 3.80M |
Full Balance SheetCash Flow
| Operating Cash Flow | -4.25M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 27,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -4.25M |
| FCF Per Share | -$2.07 |
Full Cash Flow StatementMargins
Gross margin is 34.32%, with operating and profit margins of -101.07% and -195.94%.
| Gross Margin | 34.32% |
| Operating Margin | -101.07% |
| Pretax Margin | -195.78% |
| Profit Margin | -195.94% |
| EBITDA Margin | -100.50% |
| EBIT Margin | -101.07% |
| FCF Margin | n/a |
Dividends & Yields
RKDA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.40% |
| Shareholder Yield | -13.40% |
| Earnings Yield | -496.12% |
| FCF Yield | -226.16% |
Analyst Forecast
The average price target for RKDA is $12.00, which is 1,213.49% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.00 |
| Price Target Difference | 1,213.49% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 1, 2023. It was a reverse split with a ratio of 1:40.
| Last Split Date | Mar 1, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:40 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
